NASDAQ:CBAY

CymaBay Therapeutics Inc

Stock

USD

Last Close

32.47

21/03 20:00

Market Cap

3.73B

Beta: 0.26

Volume Today

8.35M

Avg: 1.67M

PE Ratio

−23.78

PFCF: −42.19

Overview Financials API

Income Statement Balance Sheet Cash Flow Key Metrics Ratios

Excel Tearsheet

Quarterly

Yearly

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe Now Help

	Dec '14	Dec '15	Dec '16	Dec '17	Dec '18	Dec '19	Dec '20	Dec '21	Dec '22	Dec '23
revenue				10M -						31.07M -
cost of revenue										681K -
gross profit				10M -						30.39M -
selling and marketing expenses
general and administrative expenses	8.19M -	8.87M 8.38%	9.64M 8.73%	12.39M 28.43%	14.38M 16.10%	19.24M 33.77%	17.43M 9.42%	23.04M 32.22%	25.12M 9.01%	51.95M 106.85%
selling general and administrative expenses	8.19M -	8.87M 8.38%	9.64M 8.73%	12.39M 28.43%	14.38M 16.10%	19.24M 33.77%	17.43M 9.42%	23.04M 32.22%	25.12M 9.01%	51.95M 106.85%
research and development expenses	15.82M -	17.03M 7.60%	15.94M 6.37%	18.94M 18.80%	58.12M 206.92%	83.84M 44.24%	35.88M 57.20%	64.54M 79.87%	68.00M 5.35%	80.12M 17.83%
other expenses	-7.23M -	11.12M 253.86%	76K 99.32%	-5.77M 7,696.05%	-3.29M 43.05%	5.08M 254.35%				1.76M -
cost and expenses	24.01M -	25.90M 7.87%	25.59M 1.20%	31.32M 22.43%	72.50M 131.46%	103.08M 42.16%	53.31M 48.28%	87.58M 64.30%	93.11M 6.31%	132.75M 42.57%
operating expenses	24.01M -	25.90M 7.87%	25.59M 1.20%	31.32M 22.43%	72.50M 131.46%	103.08M 42.16%	53.31M 48.28%	87.58M 64.30%	93.11M 6.31%	132.07M 41.84%
interest expense	755K -	913K 20.93%	1.34M 46.44%	1.08M 19.22%	336K 68.89%			2.58M -	14.91M 477.12%	18.95M 27.09%
ebitda	-31.14M -	-14.59M 53.14%	-25.30M 73.39%	-26.44M 4.49%	-71.70M 171.16%	-97.73M 36.31%	-53.38M 45.38%	-86.73M 62.47%	-91.09M 5.04%	-101.00M 10.87%
operating income	-24.01M -	-25.90M 7.87%	-25.59M 1.20%	-21.32M 16.65%	-72.50M 240%	-108.15M 49.16%	-52.60M 51.36%	-87.58M 66.50%	-93.11M 6.31%	-101.68M 9.20%
depreciation and amortization	18K -	22K 22.22%	29K 31.82%	35K 20.69%	105K 200%	10.42M 9,820.95%	-778K 107.47%	855K 209.90%	2.02M 135.91%	681K 66.24%
total other income expenses net	-7.23M -	11.12M 253.86%	76K 99.32%	-5.77M 7,696.05%	-3.69M 36.00%	5.34M 244.57%	1.62M 69.75%	-2.42M 249.50%	-12.89M 433.53%	-3.69M 71.37%
income before tax	-31.92M -	-15.53M 51.35%	-26.67M 71.75%	-27.56M 3.32%	-72.55M 163.27%	-102.81M 41.71%	-50.99M 50.41%	-90.00M 76.52%	-106.00M 17.78%	-105.37M 0.60%
income tax expense	-6.47M -	12.03M 285.91%	1.41M 88.26%	-4.69M 432.13%	293K 106.24%	-572K 295.22%	-2.32M 305.77%	2.58M 211.29%	12.89M 399.03%
net income	-31.92M -	-15.53M 51.35%	-26.67M 71.75%	-27.56M 3.32%	-72.55M 163.27%	-102.24M 40.92%	-48.66M 52.40%	-92.58M 90.24%	-118.89M 28.42%	-105.37M 11.37%
weighted average shs out	12.05M -	18.90M 56.86%	23.45M 24.06%	34.90M 48.86%	57.81M 65.62%	67.03M 15.96%	68.89M 2.77%	71.06M 3.14%	87.80M 23.57%	106.20M 20.96%
weighted average shs out dil	12.05M -	18.92M 57.00%	23.45M 23.95%	34.90M 48.86%	57.84M 65.71%	67.03M 15.90%	68.89M 2.77%	71.06M 3.14%	87.80M 23.57%	106.20M 20.96%
eps	-2.65 -	-0.82 69.06%	-1.14 39.02%	-0.79 30.70%	-1.25 58.23%	-1.53 22.40%	-0.71 53.59%	-1.30 83.10%	-1.35 3.85%	-0.99 26.67%
epsdiluted	-2.65 -	-0.82 69.06%	-1.14 39.02%	-0.79 30.70%	-1.25 58.23%	-1.53 22.40%	-0.71 53.59%	-1.30 83.10%	-1.35 3.85%	-0.99 26.67%

All numbers in USD (except ratios and percentages)